These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 9690971

  • 1. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR, McPhillips MA.
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [Abstract] [Full Text] [Related]

  • 2. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 3. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 4. Effects of newer antipsychotics on extrapyramidal function.
    Tarsy D, Baldessarini RJ, Tarazi FI.
    CNS Drugs; 2002 Jul; 16(1):23-45. PubMed ID: 11772117
    [Abstract] [Full Text] [Related]

  • 5. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Jul; 59 Suppl 12():23-7. PubMed ID: 9766616
    [Abstract] [Full Text] [Related]

  • 6. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
    Correll CU, Leucht S, Kane JM.
    Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
    [Abstract] [Full Text] [Related]

  • 7. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
    Pierre JM.
    Drug Saf; 2005 Mar; 28(3):191-208. PubMed ID: 15733025
    [Abstract] [Full Text] [Related]

  • 8. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Mar; 61 Suppl 4():21-6. PubMed ID: 10739327
    [Abstract] [Full Text] [Related]

  • 9. Will the new antipsychotics bring hope of reducing the risk of developing extrapyramidal syndromes and tardive dyskinesia?
    Casey DE.
    Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S19-27. PubMed ID: 9179640
    [Abstract] [Full Text] [Related]

  • 10. Motor and mental side effects of clozapine.
    Gerlach J, Peacock L.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [Abstract] [Full Text] [Related]

  • 11. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [Abstract] [Full Text] [Related]

  • 12. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM.
    J Clin Psychiatry; 2000 Sep; 61 Suppl 4():39-44. PubMed ID: 10739330
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [Abstract] [Full Text] [Related]

  • 14. Tolerability of atypical antipsychotics.
    Stanniland C, Taylor D.
    Drug Saf; 2000 Mar; 22(3):195-214. PubMed ID: 10738844
    [Abstract] [Full Text] [Related]

  • 15. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH.
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [Abstract] [Full Text] [Related]

  • 16. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [Abstract] [Full Text] [Related]

  • 17. Managing antipsychotic-induced acute and tardive dystonia.
    Raja M.
    Drug Saf; 1998 Jul; 19(1):57-72. PubMed ID: 9673858
    [Abstract] [Full Text] [Related]

  • 18. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Schizophr Res; 1991 Jul; 4(2):109-20. PubMed ID: 1674881
    [Abstract] [Full Text] [Related]

  • 19. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
    Tenback DE, van Harten PN, Slooff CJ, van Os J.
    Am J Psychiatry; 2006 Aug; 163(8):1438-40. PubMed ID: 16877660
    [Abstract] [Full Text] [Related]

  • 20. Movement disorders associated with neuroleptic treatment.
    Wirshing WC.
    J Clin Psychiatry; 2001 Aug; 62 Suppl 21():15-8. PubMed ID: 11584982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.